Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Munenori Katayama

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nordisk Alkohol- & Narkotikatidskrift : NAT|December 1, 2022
Gambling and Gambling Problem Perception Questionnaire as a tool to evaluate professionals' attitudes towards problem gamblers and training programmes in JapanMunenori Katayama, Keiji Kobara, Norihito Shirakawa
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
Factors influencing stigma among healthcare professionals towards people who use illicit drugs in Japan: A quantitative studyMunenori Katayama, Kanna Sugiura, So Fujishiro, et al.
Neuropsychopharmacology Reports|October 10, 2023
Stigmatized attitudes of medical staff toward people who use drugs and their determinants in Japanese medical facilities specialized in addiction treatmentMunenori Katayama, So Fujishiro, Kanna Sugiura, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|October 7, 2024
Greater impact of COVID-19 on peer-supported addiction services than government-owned services for addiction in Japan: A nationwide 3-year longitudinal cohort studyMunenori Katayama, Sou Fujishiro, Kanna Sugiura, et al.
Neuropsychopharmacology Reports|March 3, 2026
Psychometric Properties of the Drug Stigma Scale Among Community Pharmacists Concerning Individuals Who Use Over-The-Counter DrugsMunenori Katayama, Takuya Shimane, Norihito Shirakawa, et al.
Neuropsychopharmacology Reports|July 1, 2025
Revisiting the Gateway Drug Hypothesis for Cannabis: A Secondary Analysis of a Nationwide Survey Among Community Users in JapanYuji Masataka, Munenori Katayama, Futaba Umemura, et al.
Cannabis and Cannabinoid Research|June 9, 2025
How Has Japan's Cannabis Control Act Been Amended?Yuji Masataka, Yoshiyuki Akahoshi, Munenori Katayama, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nordisk Alkohol- & Narkotikatidskrift : NAT|December 1, 2022
Gambling and Gambling Problem Perception Questionnaire as a tool to evaluate professionals' attitudes towards problem gamblers and training programmes in JapanMunenori Katayama, Keiji Kobara, Norihito Shirakawa
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
Factors influencing stigma among healthcare professionals towards people who use illicit drugs in Japan: A quantitative studyMunenori Katayama, Kanna Sugiura, So Fujishiro, et al.
Neuropsychopharmacology Reports|October 10, 2023
Stigmatized attitudes of medical staff toward people who use drugs and their determinants in Japanese medical facilities specialized in addiction treatmentMunenori Katayama, So Fujishiro, Kanna Sugiura, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|October 7, 2024
Greater impact of COVID-19 on peer-supported addiction services than government-owned services for addiction in Japan: A nationwide 3-year longitudinal cohort studyMunenori Katayama, Sou Fujishiro, Kanna Sugiura, et al.
Neuropsychopharmacology Reports|March 3, 2026
Psychometric Properties of the Drug Stigma Scale Among Community Pharmacists Concerning Individuals Who Use Over-The-Counter DrugsMunenori Katayama, Takuya Shimane, Norihito Shirakawa, et al.
Neuropsychopharmacology Reports|July 1, 2025
Revisiting the Gateway Drug Hypothesis for Cannabis: A Secondary Analysis of a Nationwide Survey Among Community Users in JapanYuji Masataka, Munenori Katayama, Futaba Umemura, et al.
Cannabis and Cannabinoid Research|June 9, 2025
How Has Japan's Cannabis Control Act Been Amended?Yuji Masataka, Yoshiyuki Akahoshi, Munenori Katayama, et al.
Pageof 1